Microcirculatory endothelial dysfunction during Endotoxemia - Insights into pathophysiology, Pathologic mechanisms and clinical relevance

被引:46
作者
Czabanka, Marcus
Peter, Christoph
Martin, Eike
Walther, Andreas
机构
[1] Heidelberg Univ, Dept Anesthesiol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Neurosurg, Klinikum Mannheim, D-68179 Heidelberg, Germany
关键词
endotoxemia; endothelial hyperpermeability; platelets; sepsis; coagulation;
D O I
10.2174/157016107782023389
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alterations in microcirculatory permeability are a characteristic of early tissue injury. Moreover, tissue edema is an early indicator of tissue dysfunction, prior to organ failure, because tissue edema is associated with impaired gas exchange, arterial hypoxemia, and may also impair tissue oxygen distribution. As a result of increased microvascular permeability, plasma fluid is lost, into the interstitial space, leading to hypovolemia. Currently, no effective pharmacological therapy is available to reduce increased permeability. High mortality rate in sepsis is still mainly associated with endothelial damage. In this regard platelets, besides leukocytes, play a major role for the development of microvascular hyperpermeability. This review considers endothelial cell dysfunction during endotoxemia including current insights into sepsis pathophysiology. New aspects of this complex pathogenesis are illustrated and their relevance for clinical sepsis therapy is emphasized.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 108 条
[1]   Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study [J].
Abraham, E ;
Reinhart, K ;
Svoboda, P ;
Seibert, A ;
Olthoff, D ;
Dal Nogare, A ;
Postier, R ;
Hempelmann, G ;
Butler, T ;
Martin, E ;
Zwingelstein, C ;
Percell, S ;
Shu, V ;
Leighton, A ;
Creasey, AA .
CRITICAL CARE MEDICINE, 2001, 29 (11) :2081-2089
[2]   Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].
Abraham, E ;
Reinhart, K ;
Opal, S ;
Demeyer, I ;
Doig, C ;
Rodriguez, AL ;
Beale, R ;
Svoboda, P ;
Laterre, PF ;
Simon, S ;
Light, B ;
Spapen, H ;
Stone, J ;
Seibert, A ;
Peckelsen, C ;
De Deyne, C ;
Postier, R ;
Pettilä, V ;
Sprung, CL ;
Artigas, A ;
Percell, SR ;
Shu, V ;
Zwingelstein, C ;
Tobias, J ;
Poole, L ;
Stolzenbach, JC ;
Creasey, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247
[3]   A critical role for nitric oxide in intestinal barrier function and dysfunction [J].
Alican, I ;
Kubes, P .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 270 (02) :G225-G237
[4]  
ARFORS KE, 1987, BLOOD, V69, P338
[5]   Septic shock [J].
Astiz, ME ;
Rackow, EC .
LANCET, 1998, 351 (9114) :1501-1505
[6]   THE ASSOCIATION OF MAST-CELLS AND ATHEROSCLEROSIS - A MORPHOLOGIC STUDY OF EARLY ATHEROSCLEROTIC LESIONS IN YOUNG-PEOPLE [J].
ATKINSON, JB ;
HARLAN, CW ;
HARLAN, GC ;
VIRMANI, R .
HUMAN PATHOLOGY, 1994, 25 (02) :154-159
[7]  
Ayala A, 1996, New Horiz, V4, P265
[8]  
Bannerman DD, 1999, LAB INVEST, V79, P1181
[9]   Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins [J].
Bannerman, DD ;
Sathyamoorthy, M ;
Goldblum, SE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35371-35380
[10]   Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock [J].
BarrosoAranda, J ;
Zweifach, BW ;
Mathison, JC ;
SchmidSchonbein, GW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 :S23-S29